<DOC>
	<DOCNO>NCT01880736</DOCNO>
	<brief_summary>This trial conduct Asia . The aim trial investigate efficacy safety flexible versus fix dose simple versus stepwise titration OD insulin degludec inadequately treated subject type 2 diabetes .</brief_summary>
	<brief_title>A Trial Investigating Efficacy Safety Flexible v . Fixed Dosing Simple vs. Stepwise Titration With Once Daily ( OD ) Insulin Degludec Inadequately Treated Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Current treatment IGlar ( insulin glargine ) without OADs ( oral antidiabetic drug ) . All antidiabetic treatment ongoing least 12 week prior randomisation , dose OADs stable period time . Please note maximum 3 OADs allow trial : metformin , sulphonylurea ( SU ) /glinides , dipeptidyl peptidase 4 ( DPPIV ) inhibitor , alfaglucosidaseinhibitors pioglitazone . Diagnosis T2DM ( type 2 diabetes mellitus ) discretion investigator least 26 week prior visit 1 ( Screening visit ) HbA1c 7.09.5 % ( inclusive ) central laboratory analysis Body mass index ( BMI ) equal 35 kg/m^2 Any chronic disorder severe disease , opinion Investigator might jeopardise subject 's safety compliance protocol Stroke ; decompensated heart failure New York Heart Association ( NYHA ) class III IV ; myocardial infarction ; unstable angina pectoris ; coronary arterial bypass graft angioplasty ; within last 26 week prior Visit 1 ( Screening visit ) Impaired renal function , define serumcreatinine high equal 1.4 mg/dL male higher equal 1.3 mg/dL female Current past ( within last 5 year ) malignant neoplasm ( except basal cell squamous cell skin carcinoma ) Treatment glucoselowering agent ( ) state inclusion criterion period 12 week prior randomisation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>